Kookmin University (President Jeong Seung Ryul) has established an industry-academic partnership with MFC Co., Ltd., a specialized developer and manufacturer of active pharmaceutical ingredients (API) and core pharmaceutical materials. On Wednesday, January 7th, the university held an opening ceremony and launched the ‘MFC AI Formulation Research Center’ within its Industrial Pharmacy Research Laboratory.

This center launch is regarded as a representative industry-academia collaboration case, combining Kookmin University's accumulated AI-based formulation design research achievements with the company's practical verification and commercialization capabilities. Professor Kim Joo Eun of Kookmin University participates as a technical advisor.

Meanwhile, the opening ceremony was attended by key industry-academia stakeholders, including Kookmin University President Jeong Seung Ryul, Professor Kim Joo Eun, and Hwang Sung Kwan, CEO of MFC Co., Ltd., who shared the significance of the research center's launch.

The newly established MFC AI Formulation Research Center will build the foundational technology to realize MFC Co., Ltd.‘s core project, the 'Non-Stop Solution Project: From Active Pharmaceutical Ingredients to Finished Dosage Forms’. It will pursue formulation research for new drug development, support partner companies in developing pharmaceutical formulations, and secure core technologies for entering the finished dosage form sector.

Kookmin University President Jeong Seung Ryul stated, “The launch of this AI Formulation Research Center is a meaningful achievement connecting Kookmin University's AI and pharmaceutical convergence research capabilities to industrial innovation,” adding, “Kookmin University will continue to contribute to strengthening the competitiveness of the national bio-pharmaceutical industry through practical industry-academia collaboration.”

Professor Kim Joo Eun remarked, “AI-driven pharmaceutical formulation design is a core field that can dramatically enhance the efficiency and success potential of new drug and improved drug development.” She continued, “By combining the technical expertise of Kookmin University's research team with the industrial infrastructure of MFC Co., Ltd., we will implement a data-driven pharmaceutical development model spanning from raw materials to finished products.”